Logo image of BHAT

BLUE HAT INTERACTIVE ENTERTA (BHAT) Stock Fundamental Analysis

NASDAQ:BHAT - Nasdaq - KYG1329V1142 - Common Stock - Currency: USD

1.88  -0.08 (-4.08%)

After market: 1.8501 -0.03 (-1.59%)

Fundamental Rating

1

Overall BHAT gets a fundamental rating of 1 out of 10. We evaluated BHAT against 503 industry peers in the Entertainment industry. BHAT may be in some trouble as it scores bad on both profitability and health. BHAT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BHAT has reported negative net income.
BHAT had a negative operating cash flow in the past year.
In the past 5 years BHAT reported 4 times negative net income.
BHAT had negative operating cash flow in 4 of the past 5 years.
BHAT Yearly Net Income VS EBIT VS OCF VS FCFBHAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

The Return On Assets of BHAT (-12.69%) is worse than 69.44% of its industry peers.
BHAT has a Return On Equity (-29.75%) which is in line with its industry peers.
Industry RankSector Rank
ROA -12.69%
ROE -29.75%
ROIC N/A
ROA(3y)-26.27%
ROA(5y)-44.9%
ROE(3y)-51.16%
ROE(5y)-103.15%
ROIC(3y)N/A
ROIC(5y)N/A
BHAT Yearly ROA, ROE, ROICBHAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Gross Margin of BHAT (10.53%) is worse than 79.17% of its industry peers.
BHAT's Gross Margin has declined in the last couple of years.
BHAT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.32%
GM growth 5Y-31.22%
BHAT Yearly Profit, Operating, Gross MarginsBHAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

BHAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
BHAT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BHAT has been increased compared to 5 years ago.
The debt/assets ratio for BHAT has been reduced compared to a year ago.
BHAT Yearly Shares OutstandingBHAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K 500K
BHAT Yearly Total Debt VS Total AssetsBHAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BHAT has an Altman-Z score of -0.54. This is a bad value and indicates that BHAT is not financially healthy and even has some risk of bankruptcy.
BHAT has a worse Altman-Z score (-0.54) than 70.83% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that BHAT is not too dependend on debt financing.
BHAT has a better Debt to Equity ratio (0.00) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.54
ROIC/WACCN/A
WACC9.12%
BHAT Yearly LT Debt VS Equity VS FCFBHAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 1.71 indicates that BHAT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.71, BHAT is in the better half of the industry, outperforming 73.61% of the companies in the same industry.
BHAT has a Quick Ratio of 1.71. This is a bad value and indicates that BHAT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.12, BHAT is doing worse than 90.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.12
BHAT Yearly Current Assets VS Current LiabilitesBHAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.55% over the past year.
The Revenue for BHAT has decreased by -74.32% in the past year. This is quite bad
Measured over the past years, BHAT shows a decrease in Revenue. The Revenue has been decreasing by -4.43% on average per year.
EPS 1Y (TTM)74.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.58%
Revenue 1Y (TTM)-74.32%
Revenue growth 3Y7.82%
Revenue growth 5Y-4.43%
Sales Q2Q%-79.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHAT Yearly Revenue VS EstimatesBHAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHAT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHAT Price Earnings VS Forward Price EarningsBHAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHAT Per share dataBHAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BHAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE HAT INTERACTIVE ENTERTA

NASDAQ:BHAT (6/13/2025, 8:00:02 PM)

After market: 1.8501 -0.03 (-1.59%)

1.88

-0.08 (-4.08%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)04-30 2025-04-30
Earnings (Next)N/A N/A
Inst Owners0.57%
Inst Owner Change-96.93%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap9.29M
Analysts0
Price TargetN/A
Short Float %2.1%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-16.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS3.85
BVpS6.48
TBVpS6.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.69%
ROE -29.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.53%
FCFM N/A
ROA(3y)-26.27%
ROA(5y)-44.9%
ROE(3y)-51.16%
ROE(5y)-103.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.32%
GM growth 5Y-31.22%
F-Score4
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 0.12
Altman-Z -0.54
F-Score4
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-74.32%
Revenue growth 3Y7.82%
Revenue growth 5Y-4.43%
Sales Q2Q%-79.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.29%
OCF growth 3YN/A
OCF growth 5YN/A